ESCO Technologies
ESE
256.90
-11.32
-4.22%
ESCO Technologies
US · ESE
#1763 by market cap
Listed 1970
256.90
-11.32
-4.22%
Live - 5344 symbols - heartbeat 429s ago
· 2026-10-08 07:30
Pre-market
254.70
-0.86%
After-hours
256.90
0.00%
- Market cap
- 6.66B
- P/E (TTM)i
- 21.14
- P/Bi
- 4.12
- EPSi
- 11.55
- Div yieldi
- 0.12%
- 52W posi
- 38%
Reader sentiment
Are you bullish or bearish on ESE?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 6.17, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +19.18% YoY
Margins
- Gross margin
- 42.09%
- Operating margin
- 15.81%
- Net margin
- 27.32%
Key ratios & quality
- Enterprise valuei
- 6.74B
- PEG ratioi
- 0.39
- Altman Z-Scorei
- 6.17
PEG uses trailing P/E against the 3-year net income growth rate (53.76%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 683.65M | 726.04M | 730.47M | 715.44M | 857.50M | 855.79M | 919.13M | 1.10B |
| Gross profit | 263.94M | 288.05M | 272.16M | 270.40M | 332.05M | 353.11M | 388.57M | 461.09M |
| Selling & admin expenses | 153.07M | 162.73M | 159.49M | 167.53M | 195.13M | 203.46M | 208.20M | 234.64M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 93.61M | 106.82M | 90.86M | 82.03M | 110.98M | 120.70M | 147.57M | 173.13M |
| Pretax profit | 81.09M | 97.88M | 36.41M | 80.67M | 106.44M | 110.37M | 130.95M | 152.85M |
| Tax | -5.17M | 20.39M | 13.51M | 17.18M | 24.12M | 24.68M | 28.33M | 36.55M |
| Net profit | 92.14M | 81.04M | 99.41M | 63.50M | 82.32M | 92.55M | 101.88M | 299.22M |
| Basic EPS | 4 | 3 | 4 | 2 | 3 | 4 | 4 | 12 |
| Diluted EPS | 3.54 | 3.10 | 3.81 | 2.42 | 3.16 | 3.58 | 3.94 | 11.55 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 231.78M | 296.34M | 352.67M | 289.66M | 309.34M | 339.03M |
| Gross profit | 99.27M | 121.99M | 149.44M | 119.92M | 131.32M | 141.52M |
| Selling & admin expenses | 54.29M | 62.04M | 63.33M | 61.21M | 62.83M | 71.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 36.99M | 43.20M | 65.52M | 38.39M | 48.07M | 50.18M |
| Pretax profit | 34.42M | 33.07M | 59.57M | 35.48M | 43.86M | 40.95M |
| Tax | 8.04M | 8.31M | 14.71M | 6.79M | 10.31M | 8.22M |
| Net profit | 31.03M | 26.07M | 218.65M | 28.69M | 34.73M | 32.74M |
| Basic EPS | 1 | 1 | 8 | 1 | 1 | 1 |
| Diluted EPS | 1.20 | 1.01 | 8.43 | 1.11 | 1.34 | 1.26 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 396.02M | 495.19M | 443.29M | 466.15M | 572.62M | 581.10M | 668.65M | 688.51M |
| Cash & ST investments | 30.48M | 61.81M | 52.56M | 56.23M | 97.72M | 41.87M | 65.96M | 101.35M |
| Inventory | 135.42M | 124.96M | 135.30M | 147.15M | 162.40M | 184.07M | 195.47M | 217.81M |
| Total assets | 1.27B | 1.47B | 1.37B | 1.58B | 1.65B | 1.68B | 1.84B | 2.41B |
| Total current liabilities | 200.53M | 251.64M | 255.48M | 275.00M | 318.13M | 314.65M | 349.85M | 508.15M |
| Short-term debt | 20.00M | 20.00M | 22.37M | 20.00M | 20.00M | 20.00M | 20.00M | 20.00M |
| Long-term debt | 200.00M | 265.00M | 40.00M | 134.00M | 133.00M | 82.00M | 102.00M | 166.00M |
| Total liabilities | 505,712,000.00 | 640,498,000.00 | 411,160,000.00 | 557,649,000.00 | 606,299,000.00 | 552,072,000.00 | 601,270,000.00 | 869,517,000.00 |
| Total equity | 759.41M | 826.22M | 959.03M | 1.02B | 1.05B | 1.13B | 1.24B | 1.54B |
| Retained earnings | 606.84M | 684.74M | 775.83M | 830.99M | 905.02M | 989.32M | 1.08B | 1.37B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 660.75M | 754.72M | 688.51M | 689.65M | 726.79M | 755.51M |
| Cash & ST investments | 57.40M | 78.72M | 101.35M | 103.82M | 92.25M | 73.24M |
| Inventory | 231.20M | 237.11M | 217.81M | 227.15M | 237.09M | 240.54M |
| Total assets | 1.82B | 2.53B | 2.41B | 2.40B | 2.41B | 2.42B |
| Total current liabilities | 322.02M | 496.84M | 508.15M | 518.39M | 500.37M | 546.69M |
| Short-term debt | 20.00M | 20.00M | 20.00M | 20.51M | 20.00M | 20.00M |
| Long-term debt | 68.00M | 505.00M | 166.00M | 125.00M | 125.00M | 65.00M |
| Total liabilities | 538,334,000.00 | 1,199,771,000.00 | 869,517,000.00 | 838,135,000.00 | 820,385,000.00 | 802,741,000.00 |
| Total equity | 1.28B | 1.33B | 1.54B | 1.56B | 1.59B | 1.62B |
| Retained earnings | 1.13B | 1.16B | 1.37B | 1.40B | 1.43B | 1.46B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 93.26M | 105.14M | 82.28M | 123.14M | 135.28M | 76.89M | 127.54M | 241.94M |
| Depreciation & amortization | 33.69M | 36.00M | 41.34M | 42.05M | 48.34M | 47.71M | 52.16M | 75.02M |
| Free cash flow | 68.44M | 72.53M | 41.15M | 87.65M | 90.26M | 46.96M | 87.36M | 189.77M |
| Dividends paid | -8.28M | -8.30M | -8.32M | -8.34M | -8.27M | -8.25M | -8.25M | -8.26M |
| Stock buybacks / issuance | -- | -- | 0 | 0 | -19.88M | -12.40M | -8.00M | 0 |
| Ending cash balance | 30.48M | 61.81M | 52.56M | 56.23M | 97.72M | 41.87M | 65.96M | 101.35M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 24.10M | 73.73M | 109.94M | 68.86M | 6.42M | 58.76M |
| Depreciation & amortization | 13.07M | 22.36M | 26.62M | 26.49M | 26.84M | 26.74M |
| Free cash flow | 11.48M | 56.83M | 95.00M | 60.76M | -3.42M | 44.26M |
| Dividends paid | -2.07M | -2.07M | -2.07M | -2.07M | -2.07M | -2.07M |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 57.40M | 78.82M | 101.35M | 103.82M | 92.25M | 73.24M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 12.87 | 10.22 | 11.41 | 6.41 | 7.96 | 8.49 | 8.60 | 21.54 |
| ROA %i | 7.30 | 5.93 | 7.18 | 4.30 | 5.09 | 5.55 | 5.79 | 14.08 |
| ROIC %i | 10.23 | 8.38 | 9.95 | 5.87 | 7.09 | 7.96 | 8.55 | 19.75 |
| 5-year avg ROE %i | 7.25 | 9.28 | 10.05 | 9.80 | 9.72 | 8.85 | 8.52 | 10.60 |
| EBIT margin %i | 12.54 | 13.61 | 6.34 | 11.59 | 12.98 | 13.36 | 14.14 | 15.55 |
| FCF / sales %i | 8.18 | 7.33 | 5.61 | 12.25 | 10.53 | 4.41 | 7.72 | 17.32 |
| Current ratioi | 1.97 | 1.97 | 1.74 | 1.70 | 1.80 | 1.85 | 1.91 | 1.35 |
| Quick ratioi | 1.23 | 1.31 | 1.14 | 1.08 | 1.22 | 1.20 | 1.01 | 0.88 |
| Debt / assetsi | 17.39 | 19.43 | 5.78 | 11.54 | 10.75 | 8.23 | 8.53 | 9.56 |
| LT debt / equityi | 26.34 | 32.07 | 5.92 | 15.89 | 15.06 | 10.48 | 11.06 | 13.65 |
| Interest coveragei | 11.06 | 13.17 | 6.91 | 36.77 | 22.94 | 14.56 | 9.52 | 9.73 |
| Revenue CAGR (3Y) %i | 8.36 | 8.31 | 2.13 | 1.53 | 5.70 | 5.42 | 8.71 | 8.50 |
| Net income CAGR (3Y) %i | 29.41 | 20.88 | 22.79 | -11.67 | 0.52 | -2.36 | 17.07 | 53.76 |
| FCF CAGR (3Y) %i | 13.83 | 12.20 | 12.88 | 8.59 | 7.56 | 4.50 | -0.11 | 28.11 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 9.66 | 9.11 | 21.54 | 21.76 | 21.53 | 21.39 |
| ROA %i | 6.56 | 5.30 | 14.08 | 14.52 | 14.60 | 12.73 |
| ROIC %i | 9.22 | 7.83 | 19.75 | 20.31 | 20.28 | 18.11 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 15.44 | 14.34 | 15.55 | 15.44 | 15.25 | 15.42 |
| FCF / sales %i | 11.17 | 13.05 | 17.32 | 19.14 | 16.76 | 15.23 |
| Current ratioi | 2.05 | 1.52 | 1.35 | 1.33 | 1.45 | 1.38 |
| Quick ratioi | 1.24 | 0.82 | 0.88 | 0.84 | 0.90 | 0.86 |
| Debt / assetsi | 6.83 | 22.51 | 9.56 | 7.88 | 7.93 | 5.34 |
| LT debt / equityi | 8.14 | 41.36 | 13.65 | 10.79 | 10.77 | 6.75 |
| Interest coveragei | 11.98 | 8.76 | 9.73 | 9.97 | 10.38 | 10.41 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Aerospace & Defense (A&D) is the largest reported line at 49.61% of revenue, across 3 reported segments.
- Utility Solutions Group (USG) follows at 29.49%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Aerospace & Defense (A&D)49.61%
Utility Solutions Group (USG)29.49%
Test20.90%
Quote time 2026-10-08 07:30:59 · For reference only, not investment advice and not tailored to your situation.